³Ô¹Ï±¬ÁÏ Falcon works with ³Ô¹Ï±¬ÁÏ clinical, regulatory, and safety applications to increase speed and lower costs<\/i><\/p>\n
PLEASANTON, CA \u2014 May 27, 2026 \u2014 <\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced ³Ô¹Ï±¬ÁÏ Falcon, an agentic platform and standard agents for life sciences\u2019 major drug development processes. Falcon works with ³Ô¹Ï±¬ÁÏ Development Cloud<\/a> applications in clinical, regulatory, and safety to reduce cost, increase speed, and maintain compliance for biopharmas of all sizes. The initial focus areas are trial master file document intake and quality control, health authority correspondence in regulatory, and safety case triage and intake.<\/p>\n \u201cFalcon is a major initiative for ³Ô¹Ï±¬ÁÏ and our first offering in agentic labor,\u201d said Peter Gassner, founder and CEO, ³Ô¹Ï±¬ÁÏ Systems. \u201cI\u2019m excited to partner with customers and help the industry lower costs and increase speed in drug development with Falcon.\u201d<\/p>\n Planned for early adopter availability in November 2026, Falcon is part of ³Ô¹Ï±¬ÁÏ AI, ³Ô¹Ï±¬ÁÏ\u2019s industry-specific AI solutions for life sciences.<\/p>\n About ³Ô¹Ï±¬ÁÏ Systems<\/strong> ³Ô¹Ï±¬ÁÏ Forward-Looking Statements<\/strong> \nContact:<\/strong><\/p>\n \nDeivis Mercado
\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2026, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 13 and 14), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n
\n³Ô¹Ï±¬ÁÏ Systems
\n925-226-8821
\ndeivis.mercado@veeva.com<\/a>\n<\/p>\n